SWTX - SpringWorks Therapeutics, Inc.

QQQ $ 481.15 $ 6.24 (1.31 %)

DIA $ 409.09 $ 2.37 (0.58 %)

SPY $ 559.11 $ 5.30 (0.96 %)

TLT $ 97.90 $ 0.45 (0.46 %)

GLD $ 231.62 $ -0.38 (-0.16 %)

Previous Close

$ 36.96

Open

Bid

$ 37.05 x 600

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 18.00 - $ 53.92

Volume

401,713

Average Volume

Market Cap

2.74B

Beta (5Y Monthly)

$ 0.72

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-27-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-02-2023	06-30-2023	10-Q
6	05-03-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-04-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-12-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-12-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

SpringWorks Therapeutics Q2 2024 GAAP EPS ...
08/07/2024 10:38:01

SpringWorks Therapeutics (NASDAQ:SWTX) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate...

SpringWorks Therapeutics Has Completed The...
07/01/2024 10:32:15

In the second half of 2024, SpringWorks also plans to file a Marketing Authorization Application (MAA) with the European Medici...

SpringWorks Therapeutics Inc Says Terminat...
06/07/2024 20:27:06

- SEC Filing

SpringWorks Therapeutics Says Termination ...
06/07/2024 20:26:22

- SEC Filing

SpringWorks Therapeutics Says Deal Termina...
06/07/2024 20:25:37

- SEC Filing

SpringWorks Therapeutics Got Notice Of Ter...
06/07/2024 20:24:07

- SEC Filing

HC Wainwright & Co. Reiterates Buy on Spri...
06/04/2024 10:48:49

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

HC Wainwright & Co. Reiterates Buy on Spri...
05/31/2024 10:16:18

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

HC Wainwright & Co. Reiterates Buy on Spri...
05/06/2024 10:35:24

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

Springworks' Cash, Cash Equivalents And Ma...
05/02/2024 10:35:37

SpringWorks Therapeutics Q1 2024 GAAP EPS ...
05/02/2024 10:32:52

SpringWorks Therapeutics (NASDAQ:SWTX) reported quarterly losses of $(1.18) per share which missed the analyst consensus estima...

HC Wainwright & Co. Maintains Buy on Sprin...
03/06/2024 13:30:20

HC Wainwright & Co. analyst Robert Burns maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and raises the pric...

JP Morgan Maintains Overweight on SpringWo...
03/06/2024 11:38:41

JP Morgan analyst Anupam Rama maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

SpringWorks Therapeutics Has Initiated A R...
03/04/2024 11:37:23

SpringWorks Therapeutics Announces Europea...
02/29/2024 14:02:12

Barclays Maintains Overweight on SpringWor...
02/29/2024 13:26:58

Barclays analyst Peter Lawson maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

SpringWorks Therapeutics: Q4 Earnings Insi...
02/27/2024 14:00:13

SpringWorks Therapeutics Reported Q4 OGSIV...
02/27/2024 11:39:24

Wedbush Maintains Outperform on SpringWork...
02/26/2024 14:44:33

Wedbush analyst David Nierengarten maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Outperform and raises the price t...

Watching SpringWorks Therapeutics; Traders...
02/16/2024 16:48:05